Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risk and Resilience, Clinical Presentation, and Biomarker Profiles of Chronic Traumatic Encephalopathy and Related Dementias: The DIAGNOSE CTE Research Project-II

NCT06860828 is registered in ClinicalTrials.gov with Boston University as lead sponsor.

NCT NCT06860828
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06860828 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risk and Resilience, Clinical Presentation, and Biomarker Profiles of Chronic Traumatic Encephalopathy and Related Dementias: The DIAGNOSE CTE Research Project-II
Lead sponsor
Boston University
Phase
Observational
Overall status
Enrolling by invitation
Start date
April 9, 2025
Completion date
July 31, 2029
Enrollment
350 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, alzheimer disease and related dementias (adrd), brain injuries, traumatic, chronic traumatic encephalopathy (cte)